Biotech/Pharma Stocks: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV)

by Investor Ideas, Benzinga Contributor
May 13, 2011 9:00 AM | 18 seconds read |
Point Roberts, WA - May 13 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector snapshot of three companies, Aethlon Medical, Inc. AEMD, Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc. MRK and their developments and progress for the treatment of Hepatitis C Virus (HCV).
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: BiotechnologyHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!